193 related articles for article (PubMed ID: 23920322)
1. Clinicopathologic implication of hepatic progenitor cell marker expression in hepatoblastoma.
Yun WJ; Shin E; Lee K; Jung HY; Kim SH; Park YN; Yu E; Jang JJ
Pathol Res Pract; 2013 Sep; 209(9):568-73. PubMed ID: 23920322
[TBL] [Abstract][Full Text] [Related]
2. Small cells in hepatoblastoma lack "oval" cell phenotype.
Badve S; Logdberg L; Lal A; de Davila MT; Greco MA; Mitsudo S; Saxena R
Mod Pathol; 2003 Sep; 16(9):930-6. PubMed ID: 13679457
[TBL] [Abstract][Full Text] [Related]
3. High mobility group AT-hook 2 is overexpressed in hepatoblastoma.
Lee CT; Zhang L; Mounajjed T; Wu TT
Hum Pathol; 2013 May; 44(5):802-10. PubMed ID: 23134771
[TBL] [Abstract][Full Text] [Related]
4. Hepatic progenitor cells in liver cancers from Asian children.
Ward SC; Thung SN; Lim KH; Tran TT; Hong TK; Hoang PL; Jang JJ; Park YN; Abe K
Liver Int; 2010 Jan; 30(1):102-11. PubMed ID: 19793197
[TBL] [Abstract][Full Text] [Related]
5. Immunohistologic attempt to find carcinogenesis from hepatic progenitor cell in hepatocellular carcinoma.
Yamamoto T; Uenishi T; Ogawa M; Ichikawa T; Hai S; Sakabe K; Tanaka S; Kato H; Mikami S; Ikebe T; Tanaka H; Ito S; Kaneda K; Hirohashi K; Kubo S
Dig Surg; 2005; 22(5):364-70. PubMed ID: 16374007
[TBL] [Abstract][Full Text] [Related]
6. SALL4 is a marker of the embryonal subtype of hepatoblastoma.
Gnemmi V; Leteurtre E; Sudour-Bonnange H; Devisme L; Guettier C; Buob D; Leroy X
Histopathology; 2013 Sep; 63(3):425-8. PubMed ID: 23822878
[TBL] [Abstract][Full Text] [Related]
7. Stem-like cells in human hepatoblastoma.
Fiegel HC; Glüer S; Roth B; Rischewski J; von Schweinitz D; Ure B; Lambrecht W; Kluth D
J Histochem Cytochem; 2004 Nov; 52(11):1495-501. PubMed ID: 15505344
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study of hepatocyte, cholangiocyte and stem cell markers of hepatocellular carcinoma.
Shibuya M; Kondo F; Sano K; Takada T; Asano T
J Hepatobiliary Pancreat Sci; 2011 Jul; 18(4):537-43. PubMed ID: 21234612
[TBL] [Abstract][Full Text] [Related]
9. Delta-like protein (DLK) is a novel immunohistochemical marker for human hepatoblastomas.
Dezso K; Halász J; Bisgaard HC; Paku S; Turányi E; Schaff Z; Nagy P
Virchows Arch; 2008 Apr; 452(4):443-8. PubMed ID: 18236070
[TBL] [Abstract][Full Text] [Related]
10. Expression of contactin associated protein-like 2 in a subset of hepatic progenitor cell compartment identified by gene expression profiling in hepatitis B virus-positive cirrhosis.
Wang H; Gao Y; Jin X; Xiao J
Liver Int; 2010 Jan; 30(1):126-38. PubMed ID: 19889080
[TBL] [Abstract][Full Text] [Related]
11. Sarcomatoid hepatocellular carcinoma with hepatoblastoma-like features in an adult.
Cho MS; Lee SN; Sung SH; Han WS
Pathol Int; 2004 Jun; 54(6):446-50. PubMed ID: 15144405
[TBL] [Abstract][Full Text] [Related]
12. Reciprocal expression of CCAAT/enhancer binding proteins alpha and beta in hepatoblastomas and its prognostic significance.
Tomizawa M; Horie H; Yamamoto H; Matsunaga T; Sasaki F; Hashizume K; Hiyama E; Kaneko M; Suita S; Ando H; Hayashi Y; Ohnuma N; Nakagawara A
Oncol Rep; 2007 Feb; 17(2):341-4. PubMed ID: 17203171
[TBL] [Abstract][Full Text] [Related]
13. Quantification of glypican 3, β-catenin and claudin-1 protein expression in hepatoblastoma and paediatric hepatocellular carcinoma by colour deconvolution.
Zhou S; Parham DM; Yung E; Pattengale P; Wang L
Histopathology; 2015 Dec; 67(6):905-13. PubMed ID: 25939253
[TBL] [Abstract][Full Text] [Related]
14. Childhood hepatocellular carcinoma: a clinicopathological study of 12 cases with special reference to EpCAM.
Zen Y; Vara R; Portmann B; Hadzic N
Histopathology; 2014 Apr; 64(5):671-82. PubMed ID: 24138022
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification.
Akiba J; Nakashima O; Hattori S; Tanikawa K; Takenaka M; Nakayama M; Kondo R; Nomura Y; Koura K; Ueda K; Sanada S; Naito Y; Yamaguchi R; Yano H
Am J Surg Pathol; 2013 Apr; 37(4):496-505. PubMed ID: 23388123
[TBL] [Abstract][Full Text] [Related]
16. Hepatoblastomas exhibit marked
Rivas MP; Aguiar TFM; Maschietto M; Lemes RB; Caires-Júnior LC; Goulart E; Telles-Silva KA; Novak E; Cristofani LM; Odone V; Cypriano M; de Toledo SRC; Carraro DM; Escobar MQ; Lee H; Johnston M; da Costa CML; da Cunha IW; Tasic L; Pearson PL; Rosenberg C; Timchenko N; Krepischi ACV
Tumour Biol; 2020 Dec; 42(12):1010428320977124. PubMed ID: 33256542
[TBL] [Abstract][Full Text] [Related]
17. Relationship of β-catenin and postchemotherapy histopathologic changes with overall survival in patients with hepatoblastoma.
Gupta K; Rane S; Das A; Marwaha RK; Menon P; Rao KL
J Pediatr Hematol Oncol; 2012 Nov; 34(8):e320-8. PubMed ID: 22735888
[TBL] [Abstract][Full Text] [Related]
18. Activated NOTCH2 is overexpressed in hepatoblastomas: an immunohistochemical study.
Litten JB; Chen TT; Schultz R; Herman K; Comstock J; Schiffman J; Tomlinson GE; Rakheja D
Pediatr Dev Pathol; 2011; 14(5):378-83. PubMed ID: 21639801
[TBL] [Abstract][Full Text] [Related]
19. Role of p53 and β-catenin mutations in conjunction with CK19 expression on early tumor recurrence and prognosis of hepatocellular carcinoma.
Yuan RH; Jeng YM; Hu RH; Lai PL; Lee PH; Cheng CC; Hsu HC
J Gastrointest Surg; 2011 Feb; 15(2):321-9. PubMed ID: 21061181
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical evaluation of hepatoblastomas with use of the hepatocyte-specific marker, hepatocyte paraffin 1, and the polyclonal anti-carcinoembryonic antigen.
Fasano M; Theise ND; Nalesnik M; Goswami S; Garcia de Davila MT; Finegold MJ; Greco MA
Mod Pathol; 1998 Oct; 11(10):934-8. PubMed ID: 9796718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
